Tumor necrosis factor release by human monocytes stimulated with platelet-activating factor

Area of Science:

• Immunology
• Cell Biology
• Biochemistry

Background:

• Platelet-activating factor (PAF) is a phospholipid known to enhance monocyte cytotoxicity against tumor cells.
• Tumor necrosis factor alpha (TNF alpha) is a crucial cytokine involved in immune responses and host defense.

Purpose of the Study:

• To investigate the capacity of PAF to stimulate the release of TNF alpha by human monocytes.
• To characterize the dose-response relationship and receptor specificity of PAF-induced TNF alpha release.

Main Methods:

• Monocytes were stimulated with PAF, and TNF alpha synthesis and release were assessed using dot blotting and ELISA.
• Dose-response studies were performed using varying concentrations of PAF.
• PAF receptor binding was analyzed using Scatchard analysis with radiolabeled PAF ([3H]PAF).

Main Results:

• PAF induced maximal TNF alpha synthesis within 2-3 hours and maximal net release within 5-16 hours post-stimulation.
• A maximal two- to three-fold increase in TNF alpha release was observed at 10-100 pM PAF.
• LysoPAF and an optical isomer of PAF did not stimulate TNF alpha release, indicating specific receptor-mediated activation. Scatchard analysis revealed approximately 651 PAF binding sites per monocyte with a Kd of 4.7 x 10(-10) M.

Conclusions:

• PAF is a potent activator of human monocytes, stimulating the release of TNF alpha.
• The interaction between PAF and its specific receptors on monocytes is critical for TNF alpha production.
• PAF's role in TNF alpha release suggests its importance in immune surveillance and host defense against tumors.